TrialBritish journal of haematology2019

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children's Oncology Group.

Kara M Kelly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.